Literature DB >> 2805551

Relationship of bioelectrical impedance to pharmacokinetic parameters of theophylline in healthy males.

B J Zarowitz1, E Peterson, J Popovich.   

Abstract

Bioelectrical impedance is a reliable, safe, non-invasive and valid method of determining body composition, using measures of resistance and reactance by passing a low voltage alternating current through the body. This study investigates relationships between the pharmacokinetics of theophylline and parameters of bioelectrical impedance in 15 non-smoking, healthy, adult male volunteers. After an overnight fast, subjects received 5 mg/kg of aminophylline intravenously over 30 minutes. Blood samples were obtained serially over a period of 12 hours. Bioelectrical impedance measurements were made in triplicate, using a 4-electrode plethysmograph. Sera were assayed in duplicate by enzyme-mediated immunoassay (coefficient of variation less than 5%), and data were fitted to a non-compartmental regression program. An all-subsets multiple-regression technique was employed to arrive at predictive equations for theophylline clearance (CL) and volume of distribution at steady-state (Vss) using age, height, weight and mean bioelectrical impedance parameters. Equations for Vss and CL revealed p-values of less than 0.001 and coefficients of variation of 8.5 and 13.33% respectively. Although the equations display some degree of colinearity they account for 95 and 86.5% of the variability in Vss and CL respectively, and represent an innovative approach to the estimation of pharmacokinetic parameters.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2805551     DOI: 10.2165/00003088-198917030-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  20 in total

Review 1.  Monitoring serum theophylline levels.

Authors:  L Hendeles; M Weinberger; G Johnson
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

2.  Changes in liver blood flow during enzyme induction.

Authors:  E E Ohnhaus; S S Thorgeirsson; D S Davies; A Breckenridge
Journal:  Biochem Pharmacol       Date:  1971-10       Impact factor: 5.858

Review 3.  Methods for the assessment of human body composition: traditional and new.

Authors:  H C Lukaski
Journal:  Am J Clin Nutr       Date:  1987-10       Impact factor: 7.045

4.  LAGRAN program for area and moments in pharmacokinetic analysis.

Authors:  M L Rocci; W J Jusko
Journal:  Comput Programs Biomed       Date:  1983-06

5.  Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant-rate intravenous infusion.

Authors:  W L Chiou; M A Gadalla; G W Peng
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

6.  Theophylline tissue partitioning and volume of distribution in normal and dietary-induced obese rats.

Authors:  L Y Shum; W J Jusko
Journal:  Biopharm Drug Dispos       Date:  1987 Jul-Aug       Impact factor: 1.627

7.  The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.

Authors:  C J Roberts; L Jackson; M Halliwell; R A Branch
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

8.  The effect of obesity on apparent volume of distribution of theophylline.

Authors:  T M Rohrbaugh; M Danish; M C Ragni; S J Yaffe
Journal:  Pediatr Pharmacol (New York)       Date:  1982

9.  Reliability of theophylline clearance in determining chronic oral dosage regimens.

Authors:  M L Slotfeldt; C E Johnson; G Grambau; J G Weg
Journal:  Am J Hosp Pharm       Date:  1979-01

10.  Theophylline disposition in obesity.

Authors:  P Gal; W J Jusko; A M Yurchak; B A Franklin
Journal:  Clin Pharmacol Ther       Date:  1978-04       Impact factor: 6.875

View more
  5 in total

Review 1.  Clinical pharmacokinetics 1990.

Authors:  G R Matzke; W L St Peter
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

2.  Assessment of bioelectrical impedance for individualizing gentamicin therapy in neonates.

Authors:  J S Sidhu; B G Charles; E J Triggs; D I Tudehope; P H Gray; P A Steer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Individual theophylline dosing based on bioelectrical impedance analysis.

Authors:  J S Sidhu; E J Triggs; B G Charles; B A Smithurst
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

Review 4.  Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations.

Authors:  R E Kauffman; G L Kearns
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

Review 5.  Lean body mass as a predictor of drug dosage. Implications for drug therapy.

Authors:  D J Morgan; K M Bray
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.